Compare ADPT & WIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADPT | WIX |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | Israel |
| Employees | 624 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 3.7B |
| IPO Year | 2019 | 2013 |
| Metric | ADPT | WIX |
|---|---|---|
| Price | $28.51 | $78.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 22 |
| Target Price | $17.78 | ★ $134.67 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,976,000.00 | N/A |
| Revenue This Year | $3.98 | $15.80 |
| Revenue Next Year | $22.72 | $13.21 |
| P/E Ratio | ★ N/A | $28.86 |
| Revenue Growth | ★ 54.77 | N/A |
| 52 Week Low | $12.00 | $40.00 |
| 52 Week High | $28.72 | $185.99 |
| Indicator | ADPT | WIX |
|---|---|---|
| Relative Strength Index (RSI) | 73.65 | 53.59 |
| Support Level | $23.73 | $75.00 |
| Resistance Level | N/A | $82.71 |
| Average True Range (ATR) | 1.06 | 4.78 |
| MACD | 0.37 | -1.02 |
| Stochastic Oscillator | 97.40 | 36.91 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.